How to Enhance Translatability of Immunotherapies in Preclinical Models?
Time: 11:30 am
day: Conference Day 1
Details:
- Focus on BRGSF-HIS hCD34+ reconstituted mice featuring human lymphoid and myeloid compartments and syngeneic humanized mouse models
- Characterization of the immune response in the mice
- Assessment of efficacy and safety induced by cell engagers
